Clinical Trials
Envisia therapeutics releases interim Env515 phase 2 data results
Envisia Therapeutics, a clinical-stage biotechnology company focused on the development of novel extended-release therapies in ophthalmology released an interim analysis of the second cohort...
Press Releases
Arven Pharmaceuticals selects GE Healthcare’s FlexFactory to improve Turkish and regional access to biopharmaceuticals
Arven Pharmaceuticals, a Toksoz Group Company, has selected GE Healthcare’s FlexFactory manufacturing platform to expand production capacity at its facility in Kirklareli, Turkey. ...
Press Releases
MeiraGTx Awarded Target ALS Grant For Its NMD-Based Therapy for ALS
MeiraGTx, a New York and UK based gene therapy company, announced that it has been awarded a grant from Target ALS, a privately funded...
Drug Research
Sanofi and Regeneron Announce First Approval of KevzaraTM for the Treatment of Moderately
Sanofi and Regeneron Pharmaceuticals, Inc announced that Health Canada approved KevzaraTM (sarilumab), an interleukin-6 (IL-6) receptor antibody. For the treatment of...
Press Releases
MDCPartners launches new ta-Scan software that ‘will revolutionize’ the way pharmaceutical companies plan for the future
MDCPartners launches ta-Scan 5, an update of its global web-based platform that analyses clinical trial data. The new platform is set to revolutionize the...
Drug Research
Novo Nordisk enters collaboration with University of Oxford on type 2 diabetes and invests GBP 115m in new research centre
University of Oxford and Novo Nordisk announced a landmark research collaboration focused on type 2 diabetes. The partnership will enable scientists from Novo Nordisk...
Clinical Trials
Astellas and Ironwood Report Positive Top-Line Results from Phase III Linaclotide Trial
Astellas Pharma Inc and Ironwood Pharmaceuticals Inc announced top-line results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read